Real-time enrollment status for this hidradenitis suppurativa (hs) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:14 AM UTC
| NCT Number | NCT07287644 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa (HS) |
| Phase | PHASE2 |
| Target Enrollment | 210 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Bluefin Biomedicine, Inc. |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of August 28, 2026: Clinical trial NCT07287644 is currently recruiting participants. This phase2 study for hidradenitis suppurativa (hs) is actively seeking new participants at 31 locations across the United States. The study is sponsored by Bluefin Biomedicine, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287644 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287644 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.